{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:59:59Z","timestamp":1792789199475,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11606-021-07165-x","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T14:02:42Z","timestamp":1635256962000},"page":"2390-2397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["High-Cost Users of Prescription Drugs: National Health Insurance Data from South Korea"],"prefix":"10.1007","volume":"37","author":[{"given":"Dahye","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyeYeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-1807","authenticated-orcid":false,"given":"Dong-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"7165_CR1","first-page":"102","volume":"22","author":"D Pritchard","year":"2016","unstructured":"Pritchard D, Petrilla A, Hallinan S, Taylor DH, Jr., Schabert VF, Dubois RW. What Contributes Most to High Health Care Costs? Health Care Spending in High Resource Patients. J Manag Care Spec Pharm 2016;22:102-9.","journal-title":"J Manag Care Spec Pharm"},{"key":"7165_CR2","doi-asserted-by":"publisher","first-page":"E111","DOI":"10.9778\/cmajo.20140049","volume":"3","author":"PE Ronksley","year":"2015","unstructured":"Ronksley PE, McKay JA, Kobewka DM, Mulpuru S, Forster AJ. Patterns of health care use in a high-cost inpatient population in Ottawa, Ontario: a retrospective observational study. CMAJ Open 2015;3:E111-8.","journal-title":"CMAJ Open"},{"key":"7165_CR3","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1001\/jama.2013.7103","volume":"309","author":"KE Joynt","year":"2013","unstructured":"Joynt KE, Gawande AA, Orav EJ, Jha AK. Contribution of preventable acute care spending to total spending for high-cost Medicare patients. JAMA 2013;309:2572-8.","journal-title":"JAMA"},{"key":"7165_CR4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12913-014-0532-2","volume":"14","author":"LC Rosella","year":"2014","unstructured":"Rosella LC, Fitzpatrick T, Wodchis WP, Calzavara A, Manson H, Goel V. High-cost health care users in Ontario, Canada: demographic, socio-economic, and health status characteristics. BMC Health Serv Res 2014;14:532.","journal-title":"BMC Health Serv Res"},{"key":"7165_CR5","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s11606-019-05315-w","volume":"34","author":"CG Toxvaerd","year":"2019","unstructured":"Toxvaerd CG, Benthien KS, Andreasen AH, Nielsen A, Osler M, Johansen NB. Chronic Diseases in High-Cost Users of Hospital, Primary Care, and Prescription Medication in the Capital Region of Denmark. J Gen Intern Med 2019;34:2421-6.","journal-title":"J Gen Intern Med"},{"key":"7165_CR6","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s11606-020-05691-8","volume":"35","author":"D Khullar","year":"2020","unstructured":"Khullar D, Zhang Y, Kaushal R. Potentially Preventable Spending Among High-Cost Medicare Patients: Implications for Healthcare Delivery. J Gen Intern Med 2020;35:2845-52.","journal-title":"J Gen Intern Med"},{"key":"7165_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/1475-6773.12492","volume":"52","author":"D Weymann","year":"2017","unstructured":"Weymann D, Smolina K, Gladstone EJ, Morgan SG. High-Cost Users of Prescription Drugs: A Population-Based Analysis from British Columbia, Canada. Health Serv Res 2017;52:697-719.","journal-title":"Health Serv Res"},{"key":"7165_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00228-015-1849-4","volume":"71","author":"A \u00d8ymoen","year":"2015","unstructured":"\u00d8ymoen A, A. Potteg\u00e5rd, Almarsd\u00f3ttir AB. Characteristics and drug utilization patterns for heavy users of prescription drugs among the elderly: a Danish register-based drug utilization study. Eur J Clin Pharmacol 2015;71:751-8.","journal-title":"Eur J Clin Pharmacol"},{"key":"7165_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10198-012-0393-8","volume":"14","author":"LK Saastamoinen","year":"2013","unstructured":"Saastamoinen LK, Verho J. Drug expenditure of high-cost patients and their characteristics in Finland. Eur J Health Econ: HEPAC: Health Economics in Prevention and Care 2013;14:495-502.","journal-title":"Eur J Health Econ: HEPAC: Health Economics in Prevention and Care"},{"key":"7165_CR10","doi-asserted-by":"crossref","unstructured":"Kwon HY, Yang B, Godman B. Key Components of Increased Drug Expenditure in South Korea: Implications for the Future. Value in health regional issues 2015;6:14-21","DOI":"10.1016\/j.vhri.2015.01.004"},{"key":"7165_CR11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3349\/ymj.2016.57.4.1016","volume":"57","author":"JS Jo","year":"2016","unstructured":"Jo JS, Kim YM, Paek KW, Bea MH, Chun K, Lee S. Factors Contributing to Increases in Prescription Drug Expenditures Borne by National Health Insurance in South Korea. Yonsei Med J 2016;57:1016-21.","journal-title":"Yonsei Med J"},{"key":"7165_CR12","doi-asserted-by":"publisher","first-page":"681492","DOI":"10.3389\/fphar.2021.681492","volume":"12","author":"H Lee","year":"2021","unstructured":"Lee H, Park D, Kim DS. Determinants of Growth in Prescription Drug Spending Using 2010-2019 Health Insurance Claims Data. Front Pharmacol 2021;12:681492.","journal-title":"Front Pharmacol"},{"key":"7165_CR13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51.","journal-title":"J Clin Epidemiol"},{"key":"7165_CR14","volume-title":"Anatomical Therapeutic Chemical (ATC)\/Defined Daily Dose (DDD) Index","author":"WHOCC","year":"2020","unstructured":"WHOCC. Anatomical Therapeutic Chemical (ATC)\/Defined Daily Dose (DDD) Index. Oslo: WHOCC; 2020."},{"key":"7165_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1472-6904-9-11","volume":"9","author":"B Hovstadius","year":"2009","unstructured":"Hovstadius B, Astrand B, Petersson G. Dispensed drugs and multiple medications in the Swedish population: an individual-based register study. BMC Clin Pharmacol 2009;9:11.","journal-title":"BMC Clin Pharmacol"},{"key":"7165_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00228-010-0940-0","volume":"67","author":"E Pappa","year":"2011","unstructured":"Pappa E, Kontodimopoulos N, Papadopoulos AA, Tountas Y, Niakas D. Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors. Eur J Clin Pharmacol 2011;67:185-92.","journal-title":"Eur J Clin Pharmacol"},{"key":"7165_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00228-003-0678-z","volume":"59","author":"MW Nielsen","year":"2003","unstructured":"Nielsen MW, Hansen EH, Rasmussen NK. Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol 2003;59:677-84.","journal-title":"Eur J Clin Pharmacol"},{"key":"7165_CR18","doi-asserted-by":"publisher","DOI":"10.1787\/9789264266414-en","volume-title":"Tackling Wasteful Spending on Health","author":"OECD","year":"2017","unstructured":"OECD. Tackling Wasteful Spending on Health. Paris: OECD; 2017."},{"key":"7165_CR19","volume-title":"Prescribing costs in primary care","author":"Office NA","year":"2007","unstructured":"Office NA. Prescribing costs in primary care. London: NAO; 2007."},{"key":"7165_CR20","unstructured":"OECD. Health Status - OECD Statistics. Paris: OECD Publishing."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-07165-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-021-07165-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-07165-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T20:11:10Z","timestamp":1666728670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-021-07165-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7165"],"URL":"https:\/\/doi.org\/10.1007\/s11606-021-07165-x","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1186\/s12879-025-12060-5","asserted-by":"object"}]},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Conflict of Interest","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a\u00a0conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}